Aerie Pharmaceuticals to Present at Two Upcoming Investor Conferences

DURHAM, N.C.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye today announced that Richard Rubino, Chief Financial Officer, will present an Aerie overview and provide a business update at two upcoming investor conferences: Raymond James Life Sciences and MedT

Full Story →